(R)-2-(Aminomethyl)-1-(tert-butoxycarbonyl)pyrrolidine>98.0%(T)1g

ETHYL 2-(PYRAZIN-2-YL)ACETATE, 97.0%, 1g

4-(1-((TERT-BUTYLDIMETHYLSILYL)OXY)-2-METHYLPROPAN-2-YL)BENZOIC ACID, 90.0%, 500mg

3-[(dimethylcarbamoyl)oxy]-1-methylpyridin-1-ium bromide, 98.0%, 5g

1-methyl-4-nitro-3-(trifluoromethyl)-1H-pyrazole, 1g

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 0.10 µm, 1 Piece(s)

2-(8-Chloro-3-(methoxymethoxy)naphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

PHENELZINE SULFATE, 95.0%, 100mg

2-[4-(4-fluorophenoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 100mg

2-Ethyl-4-hydroxy-5-methylfuran-3(2H)-one, 95.0%, 100g

(R)-2-(1-Hydroxyethyl)pyrimidin-5-ol, 95%, 100mg

1-(Azetidin-3-yl)-N,N-dimethylmethanamine dihydrochloride, 95.0%, 250mg

4-(aminomethyl)-1-methyl-3,4-dihydro-2(1H)-quinolinone hydrochloride, 95.0%, 250mg